580 results on '"Kunju, Lakshmi P."'
Search Results
52. Supplemental Table S7 A. from The Distinctive Mutational Spectra of Polyomavirus-Negative Merkel Cell Carcinoma
53. Supplemental Figure S4 from The Distinctive Mutational Spectra of Polyomavirus-Negative Merkel Cell Carcinoma
54. Clear cell renal cell carcinoma with focal psammomatous calcifications: a rare occurrence mimicking translocation carcinoma
55. Integrative Clinical Genomics of Advanced Prostate Cancer
56. Impact of tertiary Gleason pattern 5 on prostate cancer aggressiveness: Lessons from a contemporary single institution radical prostatectomy series
57. MyProstateScore in men considering repeat biopsy: validation of a simple testing approach
58. Understanding the Relationship Between Tumor Size, Gland Size, and Disease Aggressiveness in Men With Prostate Cancer
59. Papillary renal cell carcinoma revisited: a comprehensive histomorphologic study with outcome correlations
60. Evaluation of tissue PCA3 expression in prostate cancer by RNA in situ hybridization—a correlative study with urine PCA3 and TMPRSS2-ERG
61. Challenges in Pathologic Staging of Renal Cell Carcinoma: A Study of Interobserver Variability Among Urologic Pathologists
62. Reappraisal of Morphologic Differences Between Renal Medullary Carcinoma, Collecting Duct Carcinoma, and Fumarate Hydratase–deficient Renal Cell Carcinoma
63. Accuracy of tumor segmentation from multi-parametric prostate MRI and 18F-choline PET/CT for focal prostate cancer therapy applications
64. Variant (divergent) histologic differentiation in urothelial carcinoma is under-recognized in community practice: Impact of mandatory central pathology review at a large referral hospital
65. Novel dual-color immunohistochemical methods for detecting ERG–PTEN and ERG–SPINK1 status in prostate carcinoma
66. Accuracy of Determining Small Renal Mass Management with Risk Stratified Biopsies: Confirmation by Final Pathology
67. Characterization of the EZH2-MMSET Histone Methyltransferase Regulatory Axis in Cancer
68. Targeting the MLL complex in castration-resistant prostate cancer
69. Clinicopathologic characteristics of anterior prostate cancer (APC), including correlation with previous biopsy pathology
70. Role of Transcriptional Corepressor CtBP1 in Prostate Cancer Progression
71. EZH2 and ALDH-1 mark breast epithelium at risk for breast cancer development
72. The Potential Impact of Reproducibility of Gleason Grading in Men With Early Stage Prostate Cancer Managed by Active Surveillance: A Multi-Institutional Study
73. COMPARISON OF ACCURACY OF RISK-STRATIFICATION OF SMALL RENAL MASSES (SRMS) WITH ALGORITHM BASED ON PERCUTANEOUS RENAL MASS BIOPSY (RMB) AND MASS SIZE VERSUS NOMOGRAMS BASED ON R.E.N.A.L. NEPHROMETRY SCORE (RNS): MP73-03
74. Antibody-Based Detection of ERG Rearrangement-Positive Prostate Cancer
75. Loss of 15-Hydroxyprostaglandin Dehydrogenase Expression Contributes to Bladder Cancer Progression
76. Diagnosis of 'cribriform' prostatic adenocarcinoma: an interobserver reproducibility study among urologic pathologists with recommendations
77. Large Cell Calcifying Sertoli Cell Tumor
78. Quantitative Image Analysis as an Adjunct to Manual Scoring of ER, PgR, and HER2 in Invasive Breast Carcinoma
79. Molecular profiling of ETS and non-ETS aberrations in prostate cancer patients from northern India
80. PD44-07 EFFECTIVENESS OF SERUM PSA, URINE PCA3 AND URINE TMPRSS2:ERG FUSION AS A NOVEL URINARY BIOMARKER PANEL IN CLINICAL PRACTICE
81. Metastases to the kidney: a clinicopathological study of 43 cases with an emphasis on deceptive features
82. Multiple prostate cancer cores with different Gleason grades submitted in the same specimen container without specific site designation: should each core be assigned an individual Gleason score?
83. Effect of delayed resection after initial surveillance and tumor growth rate on final surgical pathology in patients with small renal masses (SRMs)
84. Challenges in accurate registration of 3-D medical imaging and histopathology in primary prostate cancer
85. Evaluation of the Antitumor Activity of Dacomitinib in Models of Human Bladder Cancer
86. The mutational landscape of lethal castration-resistant prostate cancer
87. Papillary renal cell carcinoma with oncocytic cells and nonoverlapping low grade nuclei: expanding the morphologic spectrum with emphasis on clinicopathologic, immunohistochemical and molecular features
88. Lymphovascular Invasion of Urothelial Cancer in Matched Transurethral Bladder Tumor Resection and Radical Cystectomy Specimens
89. Urologic Pathology: CBS25-1 CLEAR CELL PAPILLARY RENAL CELL CARCINOMA
90. Uroplakin II outperforms uroplakin III in diagnostically challenging settings
91. CD38 in Advanced Prostate Cancers
92. Molecular profiling of ETS gene rearrangements in patients with prostate cancer registered in REDEEM clinical trial
93. Integrative clinical genomics of metastatic cancer
94. ERF mutations reveal a balance of ETS factors controlling prostate oncogenesis
95. Significance of flat epithelial atypia on mammotome core needle biopsy: should it be excised?
96. Use of the MyProstateScore Test to Rule Out Clinically Significant Cancer: Validation of a Straightforward Clinical Testing Approach
97. Assessment of Clinical Benefit of Integrative Genomic Profiling in Advanced Solid Tumors
98. Gleason pattern 5 is the strongest pathologic predictor of recurrence, metastasis, and prostate cancer–specific death in patients receiving salvage radiation therapy following radical prostatectomy
99. Quantitative Image Analysis as an Adjunct to Manual Scoring of ER, PgR, and HER2 in Invasive Breast Carcinoma.
100. Large Cell Calcifying Sertoli Cell Tumor: A Clinicopathologic Study of 18 Cases With Comprehensive Review of the Literature and Reappraisal of Prognostic Features.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.